Merck (MRK) Long-Term Debt Issuances (2010 - 2025)

Merck (MRK) has 11 years of Long-Term Debt Issuances data on file, last reported at $7.9 billion in Q4 2025.

• Long-Term Debt Issuances for Q4 2025 came in at $7.9 billion, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $13.9 billion (up 173587.5% YoY), and the FY2025 annual result was $13.9 billion, up 285.66% from the prior year.
• Long-Term Debt Issuances improved to $7.9 billion in Q4 2025 per MRK's latest filing, from $6.0 billion in the prior quarter.
• Over five years, Long-Term Debt Issuances peaked at $7.9 billion in Q4 2021 and troughed at -$7.0 million in Q3 2023.
• A 4-year average of $4.4 billion and a median of $6.0 billion in 2025 frame the typical range for Long-Term Debt Issuances.
• The sharpest annual moves came in 2024 and 2025: Long-Term Debt Issuances surged 85.71% in 2024, then soared 596300.0% in 2025.
• A 4-year view of Long-Term Debt Issuances shows it stood at $7.9 billion in 2021, then slumped by 100.09% to -$7.0 million in 2023, then soared by 85.71% to -$1.0 million in 2024, then soared by 791900.0% to $7.9 billion in 2025.
• Business Quant data shows MRK's Long-Term Debt Issuances at $7.9 billion in Q4 2025, $6.0 billion in Q3 2025, and -$1.0 million in Q3 2024.